Conference Coverage Series

HIV: Pregnant Moms, Babies, Routine Testing and the New Law (5 part series)
Most HIV-infected babies in the U.S. are born to mothers who have had no prenatal care, do not know they are HIV-positive, receive no offer of HIV testing, refuse HIV testing, or present late in pregnancy or while already in labor. Only by offering universal HIV testing to pregnant women can we move towards decreasing mother-to-child transmission of HIV. Rhode Island has joined other states in offering an “opt-out” testing model for pregnant women. In states were “opt-out” testing has been implemented, an increase in testing has resulted. This conference discusses the genesis for the initiative leading to the new law and the impact the law will have on obstetricians, pediatricians, pregnant women, and newborns.
Nicole Everline Alexander, MD
Paul G. Loberti, MPH
Brian Alverson, MD
Raymond Powrie, MD
Robin Neale, MT
Susan Cu-Uvin, MD
Center for AIDS Research (CFAR)
The Center for AIDS Research (CFAR) is part of a national program begun by the National Institutes of Health in 1988. There are currently 19 CFARs located at academic medical centers throughout the U.S. This series is brought to you by The Lifespan/Tufts/Brown Center for AIDS Research (CFAR), a joint research effort between Tufts and Brown Universities and their affiliated hospitals and centers.
HIV Screening: Informed Consent, Public Health and Economics  
John B. Wong, MD
2
Update on Recent Clinical Microbicide Trials  
Kenneth Mayer, MD, Professor of Medicine & Community Health, Brown: Director, Brown AIDS Program, Attending, Miriam Hospital: Adjunct Professor, Harvard University School of Public Health: Director, Fenway Community Health
Update on Behavioral Issues in Clinical Microbicide Trials  
Kathleen Morrow, PhD, Assistant Professor of Psychiatry & Human Behavior, Brown Medical School & The Miriam Hospital
1
Genital Tract Inflammation and HIV Shedding  
Brenna Anderson, MD, MSc
John Jones Surgical Society 2008: Renaissance in Vascular Surgery
The John Jones Surgical Society Day is held annually in the Spring at Columbia University Medical Center, New York. The theme for this year's Symposium is Renaissance in Vascular Surgery.
Society of Hospital Medicine – San Diego, CA - April 2008
Hospital Medicine is one of the fastest growing clinical disciplines in medicine. However, with hospitalist groups averaging less than five years in practice, hospital medicine is also one of the most rapidly evolving areas of healthcare. Hospitalists are placed squarely in the crossfire of often conflicting pressures to deliver the highest quality and safest hospital care within the scope of severely limited resources. Produced in cooperation with the Society for Hospital Medicine (SHM), QuantiaMD Hospitalist Panel members who attended the SHM annual meeting in San Diego reported on key sessions delivered at the conference to fellow panelists unable to attend the meeting. Click below to see what you missed.
Cross-Bronx HIV Debates – New York, NY
The outlook for HIV is simultaneously remarkable and futile. With early identification, proper treatment and patient adherence, the long term outlook for most HIV patients is orders of magnitude beyond what it was even five years ago. And there are now 23 FDA-approved antiretroviral drugs (ARVs) in an HIV specialist’s arsenal. However, because of the remarkable velocity of HIV transmission, HIV clinicians are tremendously challenged to give the increasing number of patients the right treatment at the right time. In this unique forum, captured in the Bronx, frontline clinicians debate differing, if not opposing, viewpoints on critical issues and challenges in caring for HIV patients.
Conferences of Retroviruses and Opportunistic Infections (CROI) – Boston, MA - February 2008
One of the most anticipated conferences among Infectious Disease and HIV specialists, the CROI conference is a leading scientific venue for clinicians serving the most challenging patient populations in all of medicine. This year’s conference in Boston saw QuantiaMD Infectious Disease Panelists summarize for their fellow panelists 28 different sessions from CROI, from studies of new drugs to patient behaviors in developing countries to new data on evolving treatment regimes. For anyone who was unable to attend CROI, click on the sessions below to receive a concise, expert summary of what you missed.
Natural Enhancers and Inhibitors of HIV Infection  
Wes Thompson, MHS, PA-C, AAHIVS
Molecular Mechanisms for 3'-Azido-3'-Dideoxythymidine-resistance Conferred by Mutations in the Connection and RNase H Domains of HIV-1 Reverse Transcriptase  
Wes Thompson, MHS, PA-C, AAHIVS
Circumventing Drug Resistance: Using the Substrate Envelope Hypothesis to Develop Robust Novel HIV-1 Protease Inhibitors  
Wes Thompson, MHS, PA-C, AAHIVS
What's Driving the US Epidemic in Men Who Have Sex with Men  
Wes Thompson, MD
8
A Prospective, Randomized, Controlled, Open-label Trial Evaluating the Effect of Therapeutic Drug Monitoring and Protease Inhibitor Dose Escalation on Viral Load Responses in Antiretroviral-experienced, HIV-infected Patients with a Normalized Inhibitory  
Steven Fine, MD, PhD
Hepatitis C Viremia following Sustained Virological Response to Pegylated Interferon and Ribavarin in HIV+ Men Who Have Sex with Men-Re-infection or Late Relapse?  
Steven Fine, MD, PhD, Assistant Professor, Department of Internal Medicine, Division of Infectious Diseases, University of Rochester School of Medicine
Searching the Genome for Determinants of Response to HIV  
Benjamin T Davis MD
3
Trial of Male Circumcision: Prevention of HSV-2 in Men and Vaginal Infections in Female Partners, Rakai, Uganda  
Kevin Armington
2
Advances in the Management of Treatment-experienced Patients: A 2nd Wave of HAART  
William Harley, MD
2nd N'Galy-Mann Lecture: A Population-based Approach to Understanding a Very Clever Virus: A Brief History of HIV Research and Services in the Rakai Health Sciences Program, Uganda  
Benjamin T Davis, MD
Elevated Levels of Interleukin-6 and D-dimer Are Associated with an Increased Risk of Death in Patients with HIV  
Steven Fine, MD, PhD
1
Challenges in Pediatric and Adolescent HIV Care  
Wes Thompson, MHS, PA-C, AAHIVS
2
Efficacy Results from the STEP Study (Merck V520 Protocol 023/HVTN 502): A Phase II Test-of-Concept Trial of the MRKAd5 HIV-1 Gag/Pol/Nef Trivalent  
Steven Fine, MD, PhD
3
Revisiting Expectations from Rapid HIV Test and Confirmation in the Emergency Department  
Amy Weinberg, MS, NP
1
ART in Africa: Beyond the Roll-out  
Benjamin T Davis, MD
1
Scientific Obstacles to an Effective HIV Vaccine  
William Harley, MD
3
Morbidity and Mortality in the HAART Era  
Wes Thompson, MHS, PA-C, AAHIVS
1
Immediate vs Deferred ART in the Setting of Acute AIDS-related Opportunistic Infection: Final Results of a Randomized Strategy Trial, ACTG A5164  
Steven Fine, MD, PhD
2
Vicriviroc, a Next Generation CCR5 Antagonist, Exhibits Potent, Sustained Suppression of Viral Replication in Treatment-experienced Adults: VICTOR-E1 48-week Results  
Wes Thompson, MHS, PA-C, AAHIVS
Re-initiation of ART in the CD4-guided ART Interruption Group in the SMART Study Lowers Risk of Opportunistic Disease or Death  
William Harley, MD, Infectious Disease Specialist, CaroMont Health
8
Safety and Activity of SCH532706, a Small Molecule Chemokine Receptor 5 Antagonist in HIV-1-infected Individuals  
Wes Thompson, MHS, PA-C, AAHIVS
Virological Correlates Associated with Treatment Failure at Week 48 in the Phase 3 Study of Maraviroc in Treatment-naïve Patients  
William Harley, MD, Infectious Disease Specialist, CaroMont Health
2
Sustained Long-term Antiviral Maintenance with Pegylated Interferon in HCV/HIV-co-infected Patients: Early Viral Response and Effect on Fibrosis in Treated and Control Subjects  
Steven Mark Fine, MD, Ph.D, Assistant Professor, Department of Internal Medicine, Division of Infectious Diseases, University of Rochester School of Medicine
2
Implementing Circumcision for HIV Prevention in Sub-Saharan Africa  
Benjamin T Davis, MD
3
Scale-up of HIV Testing in Africa  
Benjamin T Davis MD, Director, QuantiaMD Infectious Disease Panel, Infectious Disease Specialist, Massachusetts General Hospital; Associate Professor, Harvard Medical School
3
Efficacy and Safety of Once-daily Atazanavir/Ritonavir Compared to Twice-daily Lopinavir/Ritonavir, Each in Combination with Tenofovir and Emtricitabinein ARV-naive HIV-1-infected Subjects. The CASTLE Study, 48-week Results  
Wes Thompson, MHS, PA-C, AAHIVS
2
Protective Effect of Vaginal Lactobacillus on Genital HIV-1 RNA Concentrations: Longitudinal Data from a United States Cohort Study  
Kevin Armington, Clinical Director of HIV Services, Callen-Lorde Community Health Center
Login to QuantiaMD
Login
Forgot password?

Enter the email address you used to register

e.g. johnsmith@hosp.edu

Enter your QuantiaMD password

If you've forgotten your password, you can reset it here.

Join QuantiaMD
Register
It's free
I would like information about new content and promotions
I would like QuantiaMD to create my public profile for me
I have read and agree to the Participant Terms and Conditions
Submit
This completes your registration

Enter your email address associated with an institution

e.g. johnsmith@hosp.edu

This will be how you log into QuantiaMD in the future.

Enter a password

Passwords must be at least 4 characters long.

We recommended that your password be unique to QuantiaMD.

Enter your first name

Your name, credentials, title and institution are part of your profile on QuantiaMD and will be displayed to other clinicians when you comment or post on the service.

Enter your last name

Your name, credentials, title and institution are part of your profile on QuantiaMD and will be displayed to other clinicians when you comment or post on the service.

Enter your credentials

e.g. MD

Your name, credentials, title and institution are part of your profile on QuantiaMD and will be displayed to other clinicians when you comment or post on the service.

Enter your professional title

e.g. Director

Your name, credentials, title and institution are part of your profile on QuantiaMD and will be displayed to other clinicians when you comment or post on the service.

Enter your primary institution

e.g. Tufts Medical Center

Your name, credentials, title and institution are part of your profile on QuantiaMD and will be displayed to other clinicians when you comment or post on the service.

Enter your office's ZIP code or country name

e.g. 10002 or Japan

This will be used to help validate your identity and credentials.

Choose up to 3 interests

This customizes your homepage and helps us provide you with the most appropriate medical content and information.

Enter your registration code, if you were provided with one

e.g. dnpaghxbd

Your registration code is unique to you and helps QuantiaMD identify you when you join.